Regional administrative data and their role in planning, programming and controlling at regional level
DOI:
https://doi.org/10.33393/grhta.2024.3024Keywords:
Real-world data, Real-world evidence, Regression analysis, Regulatory affairsAbstract
Regional administrative data may help public administrations in organizing their information, identifying problems, defining solutions and verifying results of the actions taken.
The objective of this work is to present the discussion output of the working group (GDL) “The use of regional pharmaceutical data to facilitate health planning and outcome monitoring” which was held during the Regional Pharmaceutical Policy Forum of 2023.
The GDL focused on identifying a model for planning, programming and monitoring health resources based on the data-driven approach and on the use of already existing regional administrative data, defining some gaps and developing proposals to implement this strategy. In particular, were highlighted the needs to adopt a broader perspective that considers healthcare costs as a whole (and not, specifically, oriented towards the governance of pharmaceutical assistance), to create ad-hoc training courses focused on the use of real-world data, and, similarly to some European Countries, to move towards an open access policy (accessible data) that can be useful to improve citizens’ health protection services, in compliance with the GDPR.
Downloads
References
Palcic S, Nappi C, Sangiorgi D et al. Il sole 24ore. Sanità24. L’approccio della Asu GI per la valutazione del value-for-money delle terapie ipoglicemizzanti. I dati sanitari a supporto del processo decisionale. 12/4/2021. https://www.sanita24.ilsole24ore.com/art/aziende-e-regioni/2021-04-12/l-approccio-asu-gi-la-valutazione-value-for-money-terapie-ipoglicemizzanti-dati-sanitari-supporto-processo-decisionale-104726.php?uuid=AEebAN (Accessed January 2024)
Trifirò G, Gini R, Barone-Adesi F, et al. The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? Drug Saf. 2019;42(3):347-363. https://doi.org/10.1007/s40264-018-0732-5 PMID:30269245 DOI: https://doi.org/10.1007/s40264-018-0732-5
Trifirò G, Isgrò V, Ingrasciotta Y, et al; VALORE Project Collaborators. Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: the VALORE Project. BioDrugs. 2021;35(6):749-764. https://doi.org/10.1007/s40259-021-00498-3 PMID:34637126 DOI: https://doi.org/10.1007/s40259-021-00498-3
European Medicines Agency (EMA). Data Analysis and Real World Interrogation Network (DARWIN EU). https://www.ema.europa.eu/en/about-us/how-we-work/big-data/data-analysis-real-world-interrogation-network-darwin-eu (Accessed March 2024)
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to Global & Regional Health Technology Assessment agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.
Accepted 2024-03-30
Published 2024-04-25
